Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -6.18-66.140.2217.80-9.90

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is -6.18 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-6.18
Mar2023-66.14
Mar20220.22
Mar202117.80
Mar2020-9.90

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22
-98.76
Mar2021 17.8
Positive
Mar2020 -9.9 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses